US Stock MarketDetailed Quotes

CHRS Coherus BioSciences

Watchlist
  • 1.055
  • +0.005+0.48%
Trading May 2 10:39 ET
122.30MMarket Cap4.22P/E (TTM)

Coherus BioSciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

EPS
According to the latest financial report of Coherus BioSciences, the latest earnings per share (TTM) for the company is -0.44. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: USD

Quarterly

Loading...

FCF
Interested in knowing about Coherus BioSciences's free cash flow? The latest report shows it as 28.61M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: USD

Quarterly

Loading...

Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Coherus BioSciences shows that the company's current ratio is 1.21, indicating healthy liquidity.

Currency: USD

Quarterly

Loading...

Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Coherus BioSciences, the quick ratio is 0.88, indicating that the company can meet its short-term debt obligations.

Currency: USD

Quarterly

Loading...

ROE
Want to learn more about the financial health of Coherus BioSciences? The latest ROE figure is -174.24%, indicating that the company has stable profitability.

Currency: USD

Quarterly

Loading...

ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Coherus BioSciences, the total asset return on investment (ROA) is -10.63%.

Currency: USD

Quarterly

Loading...

Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Coherus BioSciences's latest financial report to see how their gross margin is doing - currently at 37.47%.

Currency: USD

Quarterly

Loading...

Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Coherus BioSciences, the net profit margin is -93.63%, which is a good sign for its profitability.

Currency: USD

Quarterly

Loading...

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
DexCom
DXCM
79.840
New Fortress Energy
NFE
5.980
Hutchmed (China)
HCM
15.490
4
Dorian LPG
LPG
22.120
5
Enerpac Tool
EPAC
41.665
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.